Wang Chih-Hung, Huang Chien-Hua, Chang Wei-Tien, Tsai Min-Shan, Yu Ping-Hsun, Wu Yen-Wen, Chen Wen-Jone
Department of Emergency Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
PLoS One. 2016 Nov 7;11(11):e0166148. doi: 10.1371/journal.pone.0166148. eCollection 2016.
Targeted temperature management (TTM) for in-hospital cardiac arrest (IHCA) is given different recommendation levels within international resuscitation guidelines. We aimed to identify whether TTM would be associated with favourable outcomes following IHCA and to determine which factors would influence the decision to implement TTM.
We conducted a retrospective observational study in a single medical centre. We included adult patients suffering IHCA between 2006 and 2014. We used multivariable logistic regression analysis to evaluate associations between independent variables and outcomes.
We included a total of 678 patients in our analysis; only 22 (3.2%) patients received TTM. Most (81.1%) patients met at least one exclusion criteria for TTM. In all, 144 (21.2%) patients survived to hospital discharge; among them, 60 (8.8%) patients displayed favourable neurological status at discharge. TTM use was significantly associated with favourable neurological outcome (OR: 3.74, 95% confidence interval [CI]: 1.19-11.00; p-value = 0.02), but it was not associated with survival (OR: 1.41, 95% CI: 0.54-3.66; p-value = 0.48). Arrest in the emergency department was positively associated with TTM use (OR: 22.48, 95% CI: 8.40-67.64; p value < 0.001) and having vasopressors in place at the time of arrest was inversely associated with TTM use (OR: 0.08, 95% CI: 0.004-0.42; p-value = 0.02).
TTM might be associated with favourable neurological outcome of IHCA patients, irrespective of arrest rhythms. The prevalence of proposed exclusion criteria for TTM was high among IHCA patients, but these factors did not influence the use of TTM in clinical practice or neurological outcomes after IHCA.
在国际复苏指南中,针对院内心脏骤停(IHCA)的目标温度管理(TTM)给出了不同的推荐级别。我们旨在确定TTM是否与IHCA后的良好预后相关,并确定哪些因素会影响实施TTM的决策。
我们在一个单一的医疗中心进行了一项回顾性观察研究。我们纳入了2006年至2014年间发生IHCA的成年患者。我们使用多变量逻辑回归分析来评估自变量与结局之间的关联。
我们的分析共纳入了678例患者;只有22例(3.2%)患者接受了TTM。大多数(81.1%)患者至少符合一项TTM的排除标准。总共有144例(21.2%)患者存活至出院;其中,60例(8.8%)患者出院时神经功能状态良好。使用TTM与良好的神经学结局显著相关(比值比:3.74,95%置信区间[CI]:1.19 - 11.00;p值 = 0.02),但与生存无关(比值比:1.41,95% CI:0.54 - 3.66;p值 = 0.48)。在急诊科发生心脏骤停与使用TTM呈正相关(比值比:22.48,95% CI:8.40 - 67.64;p值 < 其与生存无关(比值比:1.41,95% CI:0.54 - 3.66;p值 = 0.48)。在急诊科发生心脏骤停与使用TTM呈正相关(比值比:22.48,95% CI:8.40 - 67.64;p值 < 0.001),而心脏骤停时使用血管加压药与使用TTM呈负相关(比值比:0.08,95% CI:0.004 - 0.42;p值 = 0.02)。
TTM可能与IHCA患者良好的神经学结局相关,而与心脏骤停节律无关。在IHCA患者中,提议的TTM排除标准的患病率较高,但这些因素并未影响临床实践中TTM的使用或IHCA后的神经学结局。 0.001),而心脏骤停时使用血管加压药与使用TTM呈负相关(比值比:0.08,95% CI:0.004 - 0.42;p值 = 0.02)。
TTM可能与IHCA患者良好的神经学结局相关,而与心脏骤停节律无关。在IHCA患者中,提议的TTM排除标准的患病率较高,但这些因素并未影响临床实践中TTM的使用或IHCA后的神经学结局。